Maui Fire Department responds to CO2 event in Kahului Monday night The Maui Fire Department (MFD) Monday responded at ...
PP02.05 Initial Results from RESOLVE, a Phase 1b Dose-Escalation Study of EP-104GI (Extended-Release Fluticasone ...
(Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, ...
First whale sighting contest begins Whatʻs your best guess? Whale season will be here in Hawaiʻi before you know it. When do ...
Data demonstrate broad activity of CBX-12 across six tumor types with a strong response rate in TOP1-naïve patients with ovarian (40%; ...
Aston Institute for Membrane Excellence held its official academic launch event on 13 SeptemberMore than 100 biologists, chemists, physicists and engineers gathered at Aston University to learn about ...
Anti-tumor clinical responses were observed in 29% (4/14) of efficacy-evaluable patients with PROC treated with TransCon IL-2 β/γ in combination ...
ESMO Poster Presentation Highlights ... relentlessly focused on the discovery and development of precisely designed cancer therapeutics, to transform what science can do for patients. Sutro's ...
Summit of the Future Explainer: The push to connect a digitally divided world and counter AI threats
A surge in the development of powerful artificial intelligence (AI) tools is already improving lives but is also bringing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback